2026 Partnering Organizations

The Biospecimen Management Consortium (BMC) is non-for-profit organization dedicated to driving sample excellence in clinical research. Founded in June 2024, the BMC purpose is to raise awareness of the importance and opportunities of biospecimen management, develop responsible standards and best practices, and advocate for change within the clinical trial ecosystem through efficiencies, policy, and thought leadership. To learn more about the BMC, please visit biospecimen-consortium.org or contact Amy Ripston, Founder and President, BMC at amy@biospecimen-consortium.org.

CISCRP offers a portfolio of services to support patient engagement, clinical research education, and clinical trial participation for study volunteers, clinical research stakeholders, and sponsor organizations. As an independent, neutral, nonprofit organization dedicated to patient outreach and education, CISCRP is uniquely positioned to assist with a variety of activities including developing plain language study specific documents and clinical trial summaries, organizing and running patient & care partner advisory boards, conducting research to better understand public perceptions about research, and hosting community engagement events.

For more information, visit CISCRP or contact Lindsey Elliott at lelliott@ciscrp.org

DiMe is a global non-profit and the professional home for all members of the digital medicine community. Together, we tackle the toughest digital medicine challenges, develop clinical-quality resources on a tech timeline, and deliver these actionable resources to the field via open-source channels and educational programs. Join us to advance the ethical, effective, equitable, and safe use of digital medicine to redefine healthcare and improve lives.

The Decentralized Trials & Research Alliance enables collaboration of stakeholders to accelerate the adoption of patient-focused, decentralized clinical trials and research within life sciences and healthcare through education and research. Our vision is to make research participation accessible to everyone, enabled by the consistent, widespread adoption of appropriate decentralized research methods.

To learn more about the DTRA & membership opportunities, please visit www.dtra.org.

ISPEP, the International Society for Patient Engagement Professionals, has a vision to connect and protect the essential work of all Patient Engagement Professionals (PEPs), who collectively amplify and evidence the patient voice in end-to-end medicines development. We are a professional home for the Patient Engagement Professionals (PEPs), where credibility, certification, capability, and collaboration define the next era of their impact across clinical research, drug development and healthcare.

Since our initiation in April 2024, we are a growing society of over 3000+ global members and associate members from over 450 organizations in pharma/life sciences, patient advocacy groups and vetted solution providers.

To become part of the movement and learn more including our membership and impact to date, visit our website ispephub.org. For sponsorship and partnership opportunities, contact Alex Charge CEO alexcharge@ispephub.org or Emma Sutcliffe CPO emmasutcliffe@ispephub.org. To propose topics for inclusion in the ISPEP calendar and global newsletter, please contact Olivia Kersey Managing Editor oliviakersey@ispephub.org

The Pistoia Alliance is a global, not-for-profit alliance that advocates for greater collaboration in life sciences R&D. Our mission is to lower the barriers to innovation through pre-competitive collaboration. We bring together stakeholders from industry, academia, and government and have more than 200 member companies working together on our projects and in our specialist communities using our proven framework for open innovation to transform R&D, advance science and generate better outcomes for all. To find out more about becoming a member of the Pistoia Alliance visit www.PistoiaAlliance.org

The Sustainable Healthcare Coalitionis a partnership of healthcare organisations that looks for the greatest opportunities to accelerate sustainable healthcare across the public and private sectors. ocusing on key obstacles and opportunities, the partnership shares data and insights to develop open-access guidance and tools for use in healthcare systems and their supply chain partners., such as the world’s first GHG life cycle assessment guidance on how to measure the carbon footprint of pharmaceuticals and medicine devices. Across our Sustainable Care Pathways and Sustainable Clinical Trials knowledge hubs, we offer standardised frameworks for evaluating the environmental impact of patient care pathways and clinical trials respectively, including methodology, guidance, and carbon calculators. For further information visit: https://shcoalition.org or contact info@shcoalition.org

TransCelerate BioPharma is a non-profit catalyst for change, bringing together leading global biopharmaceutical companies to streamline clinical trial processes and help promising therapies reach patients more quickly and safely. We deliver practical solutions that simplify trial design and execution, strengthen quality, and reduce burden across the R&D ecosystem—advancing more efficient, patient-focused clinical research through cross-industry collaboration. For more information, contact Heidi White at heidi.white@transceleratebiopharmainc.com.